Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe episode artwork

EPISODE · Oct 2, 2024 · 4 MIN

Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe

from Eyewire News: The Podcast · host Eyewire News

Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.    Learn more about your ad choices. Visit megaphone.fm/adchoices

Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.    Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe

0:00 4:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 4 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on October 2, 2024.

What is this episode about?

Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.    Learn...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!